JIOMICS
JIOMICS Internacional
JIOMICS Internacional
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>JIOMICS</strong> | VOL 5 | ISSUE 2 | DECEMBER 2015 | 1-62<br />
JOURNAL OF INTEGRATED OMICS<br />
Journal of Integrated Omics<br />
A METHODOLOGICAL JOURNAL<br />
HTTP://WWW.<strong>JIOMICS</strong>.COM<br />
Special Issue: Proceeding Abstracts of the 4 th International Congress on Analytical Proteomics (ICAP 2015)<br />
Identification of immunoreactive microbial proteins in the field of allergic<br />
diseases, and application for serodiagnosis<br />
Laurence Millon* 1,2 , Coralie Barrera 1 , Benedicte Rognon 1,2 , Adeline Rouzet 1 , Sandrine Roussel 1,2 , Michel Monod 3 , Gabriel<br />
Reboux 1,2<br />
1<br />
CNRS, University of Franche-Comté, UMR 6249 Chrono-Environnement, France. 2 University Hospital of Besançon, Department of<br />
Parasitology-Mycology, France. 3 Department of Dermatology, Laboratoire de Mycologie, Centre Hospitalier Universitaire Vaudois Lausanne,<br />
Switzerland. *Corresponding author: lmillon@chu-besancon.fr<br />
Available Online: 31 December 2015<br />
Abstract<br />
Purpose: Diagnosis of immunoallergenic pathologies due to environmental microorganisms includes detection of circulating specific<br />
antibodies. Immunoproteomics have proved to be useful for identifying the immunogenic proteins in several microorganisms linked to allergic<br />
diseases.<br />
Experimental description: With this approach, the causative microorganisms are first isolated from the environment of patients. Then<br />
the proteins are separated by two-dimensional electrophoresis and revealed by Western blotting with sera of different patients suffering from<br />
the disease compared to sera of asymptomatic exposed controls. Immunoreactive proteins are identified by mass spectrometry. Identified immunoreactive<br />
proteins found to be specific markers for the disease could be subsequently produced as recombinant antigens using various<br />
expression systems to develop ELISA tests.<br />
Results: Using recombinant antigens, standardized ELISA techniques can be developed, with sensitivity and specificity reaching 80% and<br />
90%, respectively. Such techniques have been developed in our lab for diagnosis of Farmer Lung Disease (FLD), which is the most frequent<br />
form of occupational hypersensitivity pneumonia. Combinations of recombinant antigens from the 3 main micro-organisms involved in FLD<br />
(2 fungi and one actinomycete) are being tested at the moment in a multicenter study. We also have developed an ELISA test for diagnosis<br />
Machine Operator Lung, using 2 recombinant antigens from mycobacteria.<br />
Conclusion: Immunoproteomics can be applied to any environmental microorganisms, with the aim of proposing panels of recombinant<br />
antigens able to improve the sensitivity and standardization of serologic diagnosis of hypersensitivity pneumonitis, but also other moldinduced<br />
allergic diseases such as allergic bronchopulmonary aspergillosis or asthma.<br />
Keywords: allergy; immunoproteomics; serodiagnosis; recombinant antigens.<br />
1-62: 15